Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.